Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers

Genes Chromosomes and Cancer

Volumn 29, Issue 1, 2000, Pages 16-25

  Smith, Justin S ^a   Tachibana, Issei ^a   Lee, Hyun K ^a   Qian, Junqi ^a   Pohl, Ute ^b   Mohrenweiser, Harvey W ^c   Borell, Thomas J ^a   Hosek, Sandra M ^a   Soderberg, Cheryl L ^a   Von Deimling, Andreas ^d   Perry, Arie ^e   Scheithauer, Bernd W ^a   Louis, David N ^b   Jenkins, Robert B ^a  

^a MAYO CLINIC   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^d UNIVERSITY HOSPITAL BONN   (Germany)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA;

ARTICLE; ASTROCYTOMA; CHROMOSOME 19Q; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE LOSS; GENE MAPPING; GENETIC MARKER; GLIOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OLIGODENDROGLIOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0033866013     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2264(2000)9999:9999<::AID-GCC1007>3.3.CO;2-9     Document Type: Article

References (55)

1. Agamanolis DP, Malone JM. 1995. Chromosomal abnormalities in 47 pediatric brain tumors. Cancer Genet Cytogenet 81:125-134.
2. Ashworth LK, Batzer MA, Brandriff B, Branscomb E, de Jong P, Garcia E, Games JA, Gordon LA, Lamerdin JE, Lennon G, Mohrenweiser HW, Olsen AS, Slezak T, Carrano AV. 1995. An integrated metric physical map of human chromosome 19. Nature Genet 11:422-427. Available from Internet URL: http://www-bio.llnl.gov/genome/html/chrom_map.html
3. Bello MJ, Leone PE, Vaquero J, De Campos JM, Kusak ME, Sarasa JL, Pestaña A, Rey JA. 1995. Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors. Int J Cancer 64:207-210.
4. Bigner SH, Mark J, Burger PC, Mahaley Jr MS, Bullard DE, Muhlbaier LH, Bigner DD. 1988. Specific chromosomal abnormalities in malignant human gliomas. Cancer Res 48:405-411.
5. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN. 1998. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90:1473-1479.
6. Chou D, Miyashita T, Mohrenweiser HW, Ueki K, Kastury K, Druck T, von Deimling A, Huebner K, Reed JC, Louis DN. 1996. The BAX gene maps to the glioma candidate region at 19q13.3, but is not altered in human gliomas. Cancer Genet Cytogenet 88:136-140.
7. Chung R, Whaley J, Kley N, Anderson K, Louis DN, Menon A, Hettlich C, Freiman R, Hedley-Whyte ET, Martuza R, Jenkins RB, Yandell D, Seizinger BR. 1991. TP53 gene mutations and 17p deletions in human astrocytomas. Genes Chromosomes Cancer 3:323-331.
8. Collins VP, James CD. 1993. Gene and chromosomal alterations associated with the development of human gliomas. FASEB J 7:926-930.
9. Jenkins RB, Kimmel DW, Moertel CA, Schultz CG, Scheithauer BW, Kelly PJ, Dewald GW. 1989. A cytogenetic study of 53 human gliomas. Cancer Genet Cytogenet 39:253-279.
10. Jenkins RB, Qian J, Lee HK, Huang H, Hirasawa K, Bostwick DG, Proffit J, Wilber K, Lieber MM, Liu W, Smith DI. 1998. A molecular cytogenetic analysis of 7q31 in prostate cancer. Cancer Res 58:759-766.
11. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS 3rd, Johnson BE, Scholnick MH. 1994. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440.
12. Kleihues P, Burger PC, Scheithauer BW, editors. 1992. Histological typing of tumors of the central nervous system, 2nd Ed. Berlin: Springer-Verlag.
13. Kraus JA, Koopman J, Kaskel P, Maintz D, Brandner S, Schramm J, Louis DN, Wiestler OD, von Deimling A. 1995. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 54:91-95.
14. Lane D, Crawford LV. 1979. T-antigen is bound to host prorein in SV40-transformed cells. Nature 278:261-263.
15. Lee WH, Bookstein R, Hong F, Young LJ, Shew JY, Lee EY. 1987. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235:1394-1399.
16. Levin VA, Gutin PH, Leibel S. 1993. Neoplasms of the central nervous system, In: DeVita Jr VT, Hellman S, Rosenberg SA, editors. Cancer Principles And Practice Of Oncology, 4th ed. Philadelphia: Lippincott. p 1679-1737.
17. Li J, Yen C, Liaw D, Podsypanina K, Rose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittman M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. 1997. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947.
18. Linzer DI, Levine AJ. 1979. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17:43-52.
19. Litofsky NS, Hinton D, Raffel C. 1994. The lack of a role for p53 in astrocytomas in pediatric patients. Neurosurgery 34:967-973.
20. Louis DN. 1997. A molecular genetic model of astrocytoma histopathology. Brain Pathol 7:755-764.
21. Louis DN, Gusella JF. 1995. A tiger behind many doors: multiple genetic pathways to malignant glioma. Trends Genet 11:412-415.
22. Maintz D, Fiedler K, Koopman J, Rollerbrocker B, Nechev S, Lenartz D, Stangl AP, Louis DN, Schramm J, Wiestler OD, von Deimling A. 1997. Molecular genetic evidence for subtypes of oligoastrocytomas. J Neuropathol Exp Neurol 56:1098-1104.
23. Mollenhauer J, Wiemann S, Scheurlen W, Korn B, Hayashi Y, Wilgenbus KK, von Deimling A, Poutska A. 1997. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumors. Nat Genet 17:32-39.
24. Nishikawa R, Furnari FB, Lin H, Arap W, Berger MS, Cavenee WK, Su Huang HJ. 1995. Loss of P161NK4 expression is frequent in high grade gliomas. Cancer Res 55:1941-1945.
25. Ohgaki H, Schäuble B, zur Hausen A, von Ammon K, Kleihues P. 1995. Genetic alterations associated with the evolution and progression of astrocytic brain tumors. Virchows Arch 427:113-118.
26. n repeats from yeast artificial chromosomes. Nucl Acids Res 20:1154.
27. Peters N, Smith JS, Tachibana I, Lee HK, Pohl U, Portier B, Louis DN, Jenkins RB. 1999. The human glia maturation factor-gamma gene: genomic structure and mutation analysis in gliomas with chromosome 19q loss. Neurogenetics 2:163-166.
28. Pohl U, Smith JS, Tachibana I, Ueki K, Lee HK, Ramaswamy S, Wu Q, Mohrenweiser HW, Jenkins RB, Louis DN. 2000. EHD2, EHD3, and EHD4 encode novel members of a highly conserved family of EH domain-containing proteins. Genomics 63:255-262.
29. Qian J, Bostwick DG, Takahashi S, Borell TJ, Herath JF, Lieber MM, Jenkins RB. 1995. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res 55:5408-5414.
30. Ransom DT, Ritland SR, Jenkins RB, Scheithauer BW, Kelly PJ, Kimmel DW. 1991. Loss of heterozygosity studies in human gliomas. Proc Am Assoc Cancer Res 32:302.
31. Ransom DT, Ritland SR, Moertel CA, Dahl RJ, O'Fallon JR, Scheithauer BW, Kimmel DW, Kelly PJ, Olopade OI, Diaz MO, Jenkins RB. 1992a. Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas. Genes Chromosomes Cancer 5:357-374.
32. Ransom DT, Ritland SR, Kimmel DW, Moertel CA, Dahl RJ, Scheithauer BW, Kelly PJ, Jenkins RB. 1992b. Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas. Genes Chromosomes Cancer 5:348-356.
33. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP. 1994. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 145:1175-1190.
34. Riley J, Butler R, Ogilvie D, Finniear R, Jenner D, Powell S, Anand R, Smith JC, Markham AF. 1990. A novel, rapid method for the isolation of terminal sequences from yeast artificial chromosome (YAC) clones. Nucleic Acids Res 18:2887-2890.
35. Ritland SR, Ganju V, Jenkins RB. 1995. Region-specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma. Genes Chromosomes Cancer 12:277-282.
36. Rosenberg JE, Lisle DK, Burwick JA, Ueki K, von Deimling A, Mohrenweiser HW, Louis DN. 1996. Refined deletion mapping of the chromosome 19q glioma tumor suppressor gene to the D19S412-STD interval. Oncogene 13:2483-2485.
37. Rubio MP, Correa KM, Ueki K, Mohrenweiser HW, Husella JF, von Deimling A, Louis DN. 1994. The putative glioma tumor suppressor gene on chromosome 19q maps between APOC2 and HRC. Cancer Res 54:4760-4763.
38. Smith JS, Jenkins RB. 1997. Loss of heterozygosity mapping of the chromosome 19 q-arm in human gliomas. FASEB J 11:3131.
39. Smith JS, Alderete B, Minn Y, Borell TJ, Perry A, Mohapatra G, Hosek SM, Kimmel D, O'Fallon J, Yates A, Feurerstein BG, Burger PC, Scheithauer BW, Jenkins RB. 1999. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene 18:4144-4152.
40. Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW, Jenkins RB. 2000. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 18:636-645.
41. Smith JS, Tachibana I, Pohl U, Lee HK, Thanarajasingam U, Portier BP, Ueki K, Ramaswamy S, Billings SJ, Mohrenweiser HW, Louis DN, Jenkins RB. 2000. A transcript map of the chromosome 19 q-arm glioma tumor suppressor region. Genomics 64:44-50.
42. Smith JS, Jenkins RB. 2000. Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications. Front Biosci 5:213-231. Available online at: http://www.bioscience.org/2000/v5/d/ smith/fulltext.htm
43. Steck PA, Perhouse MA, Jasser SA, Yunk WK, Lin H, Lignon AH, Lanford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV. 1997. Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers Nat Genet 15:356-362.
44. Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN. 1996. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res 56:150-153.
45. Ueki K, Ramaswamy S, Billings SJ, Mohrenweiser HW, Louis DN. 1997a. ANOVA, a putative astrocytic RNA-binding protein gene that maps to chromosome 19q13.3. Neurogenetics 1:31-36.
46. Ueki K, Ramaswamy S, Billings SJ, Mohrenweiser HW, and Louis DN. 1997b. Chromosomal localization to 19q13.3, partial genomic structure and 5′ cDNA sequence of the human symplekin gene. Somatic Cell Mol Genet 23:229-231.
47. Van Meir EG, Kikuchi T, Tada M, Li H, Diserens AC, Wojcik BE, Huang HJ, Friedman T, de Tribolet N, Cavenee WK. 1994. Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res 54:649-652.
48. von Deimling A, Louis DN, von Ammon K, Petersen I, Wiestler OD, Seizinger BR. 1992a. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas. Cancer Res 52:4277-4279.
49. von Deimling A, Eibl RH, Ohgaki H, Louis DN, von Ammon K, Petersen I, Kleihues P, Chung RY, Wiestler OD, and Seizinger BR. 1992b. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytomas. Cancer Res 52:2987-2990.
50. von Deimling A, Bender B, Jahnke R, Waha A, Kraus J, Albrecht S, Wellenreuther R, Faßbender F, Nagel J, Menon AG, Louis DN, Lenartz D, Schramm J, Wiestler OD. 1994a. Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q. Cancer Res 54:1397-1401.
51. von Deimling A, Nagel J, Bender B, Lenartz D, Schramm J, Louis DN, Wiestler OD. 1994b. Deletion mapping of chromosome 19 in human gliomas. Int J Cancer 57:676-680.
52. von Deimling A, Louis DN, Wiestler OD. 1995. Molecular pathways in the formation of gliomas. Glia 15:328-338.
53. Weber JL, May PE. 1989. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction Am J Hum Genet 44:388-396.
54. Yong WH, Ueki K, Chou D, Reeves SA, von Deimling A, Gusella JF, Mohrenweiser HW, Buckler AJ, Louis DN. 1995a. Cloning of a highly conserved human protein serine-threonine phosphatase gene from the glioma candidate region on chromosome 19q13.3. Genomics 29:533-536.
55. Yong WH, Chou D, Ueki K, Harsh GR, IV, von Deimling A, Gusella JF, Mohrenweiser HW, Louis DN. 1995b. Chromosome 19q deletions in human gliomas overlap telomeric to D19S219 and may target a 425 kb region centromeric to D19S112. J Neuropathol Exp Neurol 54:622-626.